Magnesium Therapy in Children With Cerebral Palsy

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Cerebral Palsy
Interventions
DIETARY_SUPPLEMENT

Oral magnesium sulfate

Magnesium sulfate 4% concentration in a dose of 65 mg/day for infants and children aged 1-3 years , 110 mg/day for those 3-8 years and 350 mg/day for those above 9 years .Each 1 ml of the magnesium sulfate used contains 0.325 mEq (milliequivalent) of elemental magnesium which equals to 4 mg elemental magnesium .

OTHER

Placebo

Trial Locations (1)

11381

Children's Hospital, Faculty of Medicine, Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02510222 - Magnesium Therapy in Children With Cerebral Palsy | Biotech Hunter | Biotech Hunter